ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $946 | -18.7% | 34,886 | -7.8% | 0.03% | -6.9% |
| Q2 2023 | $1,163 | -30.5% | 37,835 | -18.6% | 0.03% | -17.1% |
| Q1 2023 | $1,674 | -27.2% | 46,470 | -20.2% | 0.04% | -12.5% |
| Q4 2022 | $2,301 | -99.9% | 58,230 | +1.1% | 0.04% | -9.1% |
| Q3 2022 | $2,313,000 | -4.5% | 57,580 | 0.0% | 0.04% | +2.3% |
| Q2 2022 | $2,423,000 | +8.0% | 57,580 | 0.0% | 0.04% | +26.5% |
| Q1 2022 | $2,243,000 | -1.7% | 57,580 | +0.5% | 0.03% | +6.2% |
| Q4 2021 | $2,282,000 | +68.9% | 57,280 | +53.2% | 0.03% | +88.2% |
| Q3 2021 | $1,351,000 | -11.8% | 37,387 | 0.0% | 0.02% | -10.5% |
| Q2 2021 | $1,532,000 | -6.0% | 37,387 | 0.0% | 0.02% | -13.6% |
| Q1 2021 | $1,630,000 | +315.8% | 37,387 | +376.8% | 0.02% | +340.0% |
| Q4 2020 | $392,000 | – | 7,842 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |